European Commission paper reported COVID-19 vaccine manufacturers Pfizer/BioNtech, Moderna & Astra Zeneca/University of Oxford falsified data – committed fraud

“The candidate vaccines do not prevent SARS-COV-2 infections which makes them suspicious at best and dishonest at best since they were made to elicit immune response that targets the SARS-COV-2 Spike protein. If the immune response that is elicited by the candidate vaccines was truly targeting SARS-COV-2 Spike protein, prevention of SARS-COV-2 infections should have been their primary mechanism of action (SARS-COV-2 should not in principle be able to enter and infect cells). The fact that the candidate vaccines do not prevent SARS-COV-2 infections make the claims of more than 90% effectiveness dubious, misleading at best and dishonest at worse. As stated above, no verifiable scientific evidence is available to show that the candidate vaccines concocted and developed by Pfizer/BioNtech, Moderna and Astra Zeneca/University of Oxford are more than 90% effective. The only way to know anything about the effectiveness of the candidate vaccines is to analyze the data towards the end of the clinical trials in 2022 or to completely unseal the data for all the participants now. There is also no study of the long-term effects of the candidate vaccines. Again, one cannot cut corners when it comes to proving the effectiveness of a candidate vaccine and whether it is dangerous or not.”

CERN EC Journal of Investigative Critiques of Published Scientific Articles.

Website “commissioned by the European Commission to support their nascent Open Data policy by providing a catch-all repository for European Commission funded research” CERN EC Journal of Investigative Critiques of Published Scientific Articles

Source: DISHONEST SCIENTIFIC REPORT AND DATA FALSIFICATION WITH RESPECT TO THE EFFECTIVENESS OF THE CANDIDATE SARS-COV-2/COVID-19 VACCINES DEVELOPED BY BIONTECH/PFIZER, MODERNA AND ASTRAZENECA/UNIVERSITY OF OXFORD

Criminal Code of Canada defines COVID-19 vaccine manufacturers Pfizer/BioNtech, Moderna & Astra Zeneca/University of Oxford falsifying data to obtain regulatory approval and sale or purchase of their vaccines as Fraud

  •  (1) Every one who, by deceit, falsehood or other fraudulent means, whether or not it is a false pretence within the meaning of this Act, defrauds the public or any person, whether ascertained or not, of any property, money or valuable security or any service,

    • (a) is guilty of an indictable offence and liable to a term of imprisonment not exceeding fourteen years, where the subject-matter of the offence is a testamentary instrument or the value of the subject-matter of the offence exceeds five thousand dollars; or

    • (b) is guilty

      • (i) of an indictable offence and is liable to imprisonment for a term not exceeding two years, or

      • (ii) of an offence punishable on summary conviction,

      where the value of the subject-matter of the offence does not exceed five thousand dollars.

The United States’ SEC and FBI defines COVID-19 vaccine manufacturers’ falsifying data as securities fraud.

Generally, securities fraud occurs when someone makes a false statement about a company or the value of its stock, and others makes financial decisions based on the false information.

Securities fraud is a criminal offense that is punishable under 18 USC § 1348. The law has the intention of protecting investors against fraudulent securities, such as stocks and bonds, through the imposition of disclosing important facts related to all forms of trade securities. To become liable for the offense, one must have committed the following acts:

  • Causing to defraud another person related to a commodity transacted for a future delivery. It may include any form of a security that is included in the classification provided by the Securities and Exchange Act.
  • The commission of misrepresentation, false statements, or false promises to obtain anything of value, such as money and property, in relation to a sale or purchase of a commodity.
  • Failure to disclose material facts related to the exchange of securities and provide false statements instead.